National Over 1.20 Crore Covid Vaccine Doses Were Supplied To Private Hospitals: Centre BY Outlook Web Bureau
National Brazil Approves Import Of Bharat Biotech's Covaxin, Russia's Sputnik V BY Outlook Web Bureau
National Why Start Vaccine Centres With ‘Pomp And Splendour’ If 2nd Dose Of Covaxin Not Available: HC To Delhi Govt BY Outlook Web Bureau
National Villagers Get Mixed Shots Of Covaxin And Covishield In UP's Govt Hospital; CMO Says 'Definitely An Oversight' BY Outlook Web Bureau
National Amid Travel Fears, Bharat Biotech Says Expecting WHO Nod For Covaxin in July- September BY Outlook Web Bureau
National More Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHO BY Outlook Web Bureau
National Do Kids Need Covid Vaccines, What Are The Side Effects And Precautions, Know From Expert BY Dr. Prabhat Maheshwari
National Covaxin Effective Against UK Strain And Covid Variant Found In India: Bharat Biotech BY Outlook Web Bureau
National Covid Explained: How Phase 2 And 3 Trials For Covaxin On Kids Will Be Conducted? BY Outlook Web Bureau
National What Makes Some Vaccinated People More Susceptible To Covid-19 Than Others? Experts Answer BY Dr. Harshal R Salve and Dr. Sachin Jain
National Bharat Biotech Says Can’t Give Additional Covaxin Doses to Delhi: Manish Sisodia BY Outlook Web Bureau
National Experts Recommend Bharat Biotech’s Covaxin For Phase 2/3 Trials On 2-18-Year-Olds BY Outlook Web Bureau
National Delhi’s Covaxin Stock Will Run Out In A Day, Covishield Doses Will Last 3-4 Days: Satyendar Jain BY Outlook Web Bureau
Making A Difference Can Covaxin Neutralise 617 Variant Of Covid? Know It From Dr Anthony Fauci BY Outlook Web Bureau
National Covishield, Covaxin Offer Protection Against 'Indian Strain' Of Coronavirus, Says Study BY Outlook Web Bureau
National Bharat Biotech’s Covaxin To Cost Rs 1200 For Private Hospitals, Rs 600 For State Govts BY Outlook Web Bureau
National 21,000 People Contracted Covid-19 After Receiving First Dose Of Vaccine: Centre BY Outlook Web Bureau
National Covaxin Is 78% Effective Against Mild To Severe Covid-19 Infections: Bharat Biotech BY Outlook Web Bureau
National Bharat Biotech’s Covaxin Neutralises Multiple Coronavirus Variants: ICMR BY Outlook Web Bureau